DYN

Dyne Therapeutics, Inc.

Phase 3 AI-extracted

z-basivarsen

Myotonic Dystrophy Type 1 (DM1)

Countdown

178days

Phase 3 readout · ~ Jan 1, 2027 estimated

What's at stake Phase 3 trial results for z-basivarsen in Myotonic Dystrophy Type 1 (DM1) are due ~ Jan 1, 2027. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 8-K verified 13h ago

“Data from this cohort are planned for Q1 2027 to support a potential BLA submission for U.S. Accelerated Approval in early Q3 2027.”

Add to calendar Post on X Reddit

Provenance